Fabio Zattoni

Fabio Zattoni

Assistant Professor

Telefono: +39 049 821 8750



October 2004 /June 2010

School of Medicine, University of Verona, Italy

Medicine and Surgery Degree

Final thesis dealing with Renal Cancer Imaging Techniqe

June 2011/June 2016

Urology Clinic, University of Padua, Italy

Residency in Urology at the University of Padua


February 2019

University of Padua, Italy

Three years PhD program in Clinical and Sperimental Oncology and Immunology class 2015/16 (31th series)

Dec 2019/ mar 2021

University of Trieste

2nd Level Master degree in Surgical Andrology and gender dysphoria



June 2012

Onze-Lieve Vrouwziekenhuis Hospital, Aalst, Belgium

2-weeks Robotic Fellowship at the Urology department

Wide and various training program in robotic surgery. The training period was implemented by the participation of the 5 days ORSI Corse. During these cores he performed 6 hours on the da Vinci Simulator, web lab procedures on the pig at the Faculty of Veterinary Medicine of Ghent.

September 2012

NYU Langone Medical Center, New York, USA

One-week observership at the Urology department

May-June 2013

NYU Langone Medical Center, New York, USA

Two-months research fellowship at the Urology department

Research program on prostate target biopsy.

July 2014 / July 2015

Mayo Clinic, Rochester (MN), USA

One-year research fellowship

Research focused on prostate, bladder and penile cancers.

Main project: evaluation of prostate cancer recurrence with MRI and PET/CT scanners.

July 2014 /July 2015

Mayo Clinic, Rochester (MN), USA

Postdoctoral Diploma in Clinical and Translational


This postdoctoral diploma required 12 Mayo Graduate School didactic credits with attendance at the “Writing for Biomedical Publication” workshop, and preparation of a manuscript based on the results of a personalized clinical and translational research project.

February 2015

Surgery Centre Jesús Usón, Caceres, Spain

Hands-on training course on Laparoscopy and


1-week training accredited by the European Board of Urology at Minimally Invasive surgery.

December 2018/

February 2019

Three months Research Collaborator at Mayo Clinic



February 2017/June 2018

Consultant at Urology department, University of Udine

June 2018/January 2019

Consultant at Urology department, Gorizia Hospital, Italy

January 2019/October 2021

Consultant at Urology department, University of Udine

January 2019/June 2019

Professor under contract. Seminars in Urology for obstetrics.

January 2020/June 2020

Professor under contract. Seminars in Urology for obstetrics.

Nov 2021 till now

Assistant professor at Urology department, University of Padua


- Prostate cancer

- Urology-Oncology

- Prostate Imaging (MRI and PET/CT)

- Robotic surgery



EAU-YAU prostate cancer working groupFull member

Italian north east Uro oncology society (GUONE): Scientific Office

EAU (European Urology Association): Active member

SIU (italina Urology society): Active member



April 2014                               Top 20 European residents after a written and practical contest on Basic Laparoscopic Urological Skills.

May 2016                               Best Poster presentation at AUA meeting in San Diego, California, USA

March 2017                            Best Poster at EAU meeting in London, United Kingdom.



-Patent n. WO2016135595A1: Indirect visualization-assisted apparatus and method for positioning medical instrument

-Patent n. WO2016135594A8: Apparatus and method for positioning medical instruments assisted by indirect visualization


  1. Zattoni F, Ravelli I, Rensi M, Capobianco D, Borsatti E, Baresic T, Chiaravalloti A, Schillaci O, Alongi P, Bartolotta TV, Rambaldi I, Bartolomei M, Farsad M, Tredici M, Donner D, Chierichetti F, Trifirò G, Brugola E, Burei M, Dal Moro F, Cecchin D, Evangelista L. 10-Year Clinical Experience With 18F-Choline PET/CT: An Italian Multicenter Retrospective Assessment of 3343 Patients. Clin Nucl Med. 2020 Aug;45(8):594-603. doi: 10.1097/RLU.0000000000003125. PMID: 32558711.
  2. Zattoni F, Incerti E, Dal Moro F, Moschini M, Castellucci P, Panareo S, Picchio M, Fallanca F, Briganti A, Gallina A, Fanti S, Schiavina R, Brunocilla E, Rambaldi I, Lowe V, Karnes JR, Evangelista L. 18F-FDG PET/CT and Urothelial Carcinoma: Impact on Management and Prognosis-A Multicenter Retrospective Study. Cancers (Basel). 2019 May 20;11(5):700. doi: 10.3390/cancers11050700. PMID: 31137599; PMCID: PMC6562413.
  3. Zattoni F, Artibani W, Patel V, Montorsi F, Porpiglia F, Hampton LJ, Rocco B, Dasgupta P, Hemal AK, Mottrie A, Tewari A, Dal Moro F. Technical innovations to optimize continence recovery after robotic assisted radical prostatectomy. Minerva Urol Nefrol. 2019 Aug;71(4):324-338. doi: 10.23736/S0393-2249.19.03395-2. Epub 2019 Apr 5. PMID: 30957476.
  4. Zattoni F, Morlacco A, Matrone F, Arcicasa M, Buttazzi L, Maruzzi D, Fratino L, Lo Re G, Bortolus R. Multimodal treatment for high-risk locally-advanced prostate cancer following radical prostatectomy and extended lymphadenectomy. Minerva Urol Nefrol. 2019 Oct;71(5):508-515. doi: 10.23736/S0393-2249.19.03388-5. Epub 2019 Apr 5. PMID: 30957475.
  5. Zattoni F, Morlacco A, Zattoni F. Preoperative chronic kidney disease before radical cystectomy as predictor of oncological outcomes: a pick of the iceberg? World J Urol. 2018 Jun;36(6):993. doi: 10.1007/s00345-018-2211-0. Epub 2018 Feb 7. PMID: 29417287.
  6. Evangelista L, Zattoni F, Cassarino G, Artioli P, Cecchin D, Dal Moro F, Zucchetta P. PET/MRI in prostate cancer: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):859-873. doi: 10.1007/s00259-020-05025-0. Epub 2020 Sep 8. PMID: 32901351; PMCID: PMC8036222.
  7. Lam TBL, MacLennan S, Willemse PM, Mason MD, Plass K, Shepherd R, Baanders R, Bangma CH, Bjartell A, Bossi A, Briers E, Briganti A, Buddingh KT, Catto JWF, Colecchia M, Cox BW, Cumberbatch MG, Davies J, Davis NF, De Santis M, Dell'Oglio P, Deschamps A, Donaldson JF, Egawa S, Fankhauser CD, Fanti S, Fossati N, Gandaglia G, Gillessen S, Grivas N, Gross T, Grummet JP, Henry AM, Ingels A, Irani J, Lardas M, Liew M, Lin DW, Moris L, Omar MI, Pang KH, Paterson CC, Renard-Penna R, Ribal MJ, Roobol MJ, Rouprêt M, Rouvière O, Sancho Pardo G, Richenberg J, Schoots IG, Sedelaar JPM, Stricker P, Tilki D, Vahr Lauridsen S, van den Bergh RCN, Van den Broeck T, van der Kwast TH, van der Poel HG, van Leenders GJLH, Varma M, Violette PD, Wallis CJD, Wiegel T, Wilkinson K, Zattoni F, N'Dow JMO, Van Poppel H, Cornford P, Mottet N. EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study). Eur Urol. 2019 Dec;76(6):790-813. doi: 10.1016/j.eururo.2019.09.020. Epub 2019 Oct 3. PMID: 31587989.
  8. Evangelista L, Guttilla A, Zattoni F, Muzzio PC, Zattoni F. Utility of choline positron emission tomography/computed tomography for lymph node involvement identification in intermediate- to high-risk prostate cancer: a systematic literature review and meta-analysis. Eur Urol. 2013 Jun;63(6):1040-8. doi: 10.1016/j.eururo.2012.09.039. Epub 2012 Sep 25. PMID: 23036576.
  9. Zattoni F, Guttilla A, Evangelista L. Can (68)GA-PSMA or radiolabeled choline PET/CT guide salvage lymph node dissection in recurrent prostate cancer? Eur J Nucl Med Mol Imaging. 2016 Jul;43(8):1407-9. doi: 10.1007/s00259-016-3401-x. Epub 2016 Apr 23. PMID: 27105875.
  10. Zattoni F, Nehra A, Murphy CR, Rangel L, Mynderse L, Lowe V, Kwon E, Karnes RJ. Mid-term Outcomes Following Salvage Lymph Node Dissection for Prostate Cancer Nodal Recurrence Status Post-radical Prostatectomy. Eur Urol Focus. 2016 Dec;2(5):522-531. doi: 10.1016/j.euf.2016.01.008. Epub 2016 Feb 10. PMID: 28723518.